Insider transactions

EDGAR

CLOVER HEALTH INVESTMENTS, CORP. /DE

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
42 transactions, 2,049,799 shares
Sum of shares × price per share: 8,821,158.59

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 93

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-16 Filed 2026-11-17THORNTON JOSEPH CLAY Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)22,0994.97
109,832.03

Derived: shares × price per share. Exact value 109832.03.

1,551,783Direct (D) No— Open filing 0001801170-26-000311 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06OLDAKOWSKI JOSEPH FRANK Officer: Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)186,4030—462,300Direct (D) No
F1
  • F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of November 4, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of November 4, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on November 4, 2030.
Open filing 0001801170-26-000299 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06THORNTON JOSEPH CLAY Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)328,9470—1,573,882Direct (D) No
F1
  • F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of November 4, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of November 4, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on November 4, 2030.
Open filing 0001801170-26-000298 Read from the filing’s XML Dispute this row
2026-10-20 Filed 2026-10-20Soares Karen Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)19,2754.66
89,821.5

Derived: shares × price per share. Exact value 89821.50.

1,573,423Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001999086-26-000034 Read from the filing’s XML Dispute this row
2026-10-19 Filed 2026-10-20Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,0664.41
17,931.06

Derived: shares × price per share. Exact value 17931.06.

2,770,351Direct (D) Yes
F1, F2
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.32 to $4.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001839066-26-000057 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19THORNTON JOSEPH CLAY Officer: Interim CFO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,5914.68
21,485.88

Derived: shares × price per share. Exact value 21485.88.

1,244,935Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on October 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000280 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Wai Conrad Officer: CEO, Counterpart Health
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)23,6274.68
110,574.36

Derived: shares × price per share. Exact value 110574.36.

1,042,072Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000278 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Toy Andrew Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)62,1764.68
290,983.68

Derived: shares × price per share. Exact value 290983.68.

9,078,334Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000284 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Soares Karen Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)14,6734.68
68,669.64

Derived: shares × price per share. Exact value 68669.64.

1,592,698Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000282 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)18,2734.68
85,517.64

Derived: shares × price per share. Exact value 85517.64.

2,774,417Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000276 Read from the filing’s XML Dispute this row
2026-10-07 Filed 2026-10-07Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)2,0064.63
9,287.78

Derived: shares × price per share. Exact value 9287.78.

2,792,690Direct (D) Yes
F1, F2
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001839066-26-000054 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-05Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)8,7504.42
38,675

Derived: shares × price per share. Exact value 38675.00.

2,794,696Direct (D) Yes
F1
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting of 6.25% of restricted stock units (the RSUs) on October 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023, with a final vesting on January 3, 2027, subject to the continued service of the Reporting Person on such final vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
Open filing 0001839066-26-000052 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02Toy Andrew Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)318,8064.19
1,335,797.14

Derived: shares × price per share. Exact value 1335797.14.

9,140,510Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000242 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Torricelli Robert G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)12,4810—186,897Direct (D) No
F1
  • F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the Company) underlying a time-based restricted stock unit award (RSUs) granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.
Open filing 0001801170-26-000243 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Miller Brian James Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)12,4810—12,481Direct (D) No
F1
  • F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the Company) underlying a time-based restricted stock unit award (RSUs) granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.
Open filing 0001801170-26-000244 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-18Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)1,9214.56
8,759.76

Derived: shares × price per share. Exact value 8759.76.

2,803,446Direct (D) Yes
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
Open filing 0001839066-26-000047 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17OLDAKOWSKI JOSEPH FRANK Officer: VP OF FINANCE AND CONTROLLER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)3,1704.64
14,708.8

Derived: shares × price per share. Exact value 14708.80.

275,897Direct (D) Yes
F1
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on June 16, 2025. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
Open filing 0001801170-26-000223 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-16Wai Conrad Officer: CEO, Counterpart Health
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)300,0004.72
1,416,000

Derived: shares × price per share. Exact value 1416000.00.

1,170,056Indirect (I) By Trust.Yes
F1, F2
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $5.06, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
Open filing 0001971702-26-000017 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-15Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)9,2734.78
44,324.94

Derived: shares × price per share. Exact value 44324.94.

2,805,367Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the final 6.25% of restricted stock units (the RSUs) on September 15, 2026. The RSUs were originally granted to the Reporting Person on September 16, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001839066-26-000045 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-15Soares Karen Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)6,8464.78
32,723.88

Derived: shares × price per share. Exact value 32723.88.

1,607,371Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting of 6.25% of restricted stock units originally granted to the Reporting Person on September 15, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001999086-26-000031 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-14OLDAKOWSKI JOSEPH FRANK Officer: VP OF FINANCE AND CONTROLLER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)20,0005.16
103,200

Derived: shares × price per share. Exact value 103200.00.

279,067Direct (D) No— Open filing 0001801170-26-000218 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-17THORNTON JOSEPH CLAY Officer: Interim CFO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)17,7754.39
78,032.25

Derived: shares × price per share. Exact value 78032.25.

1,249,526Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on August 16, 2026. The RSUs were originally granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000207 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-13Soares Karen Officer: Chief Legal Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)108,6950—1,614,217Direct (D) No
F1
  • F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030.
Open filing 0001999086-26-000023 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-13THORNTON JOSEPH CLAY Officer: Interim CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)54,3470—1,267,301Direct (D) No
F1
  • F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030.
Open filing 0001801170-26-000202 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-10Toy Andrew Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)87,7984.65
408,260.7

Derived: shares × price per share. Exact value 408260.70.

9,459,316Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting on August 8, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on August 8, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001838733-26-000028 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-20Soares Karen Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)51,7004.51
233,167

Derived: shares × price per share. Exact value 233167.00.

1,505,522Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001999086-26-000021 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,8394.53
21,920.67

Derived: shares × price per share. Exact value 21920.67.

2,814,640Direct (D) Yes
F1, F2
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001839066-26-000039 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16Wai Conrad Officer: CEO, Counterpart Health
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)24,2154.67
113,084.05

Derived: shares × price per share. Exact value 113084.05.

1,145,699Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000178 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)13,1194.67
61,265.73

Derived: shares × price per share. Exact value 61265.73.

2,819,479Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000176 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16Toy Andrew Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)62,7114.67
292,860.37

Derived: shares × price per share. Exact value 292860.37.

9,547,114Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000179 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16Soares Karen Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)10,5194.67
49,123.73

Derived: shares × price per share. Exact value 49123.73.

1,557,222Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000175 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16THORNTON JOSEPH CLAY Officer: Interim CFO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,6304.67
21,622.1

Derived: shares × price per share. Exact value 21622.10.

1,212,954Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000174 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-09Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)2,3844.68
11,157.12

Derived: shares × price per share. Exact value 11157.12.

2,832,598Direct (D) Yes
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
Open filing 0001839066-26-000033 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-06Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)6,2295.26
32,764.54

Derived: shares × price per share. Exact value 32764.54.

2,834,982Direct (D) Yes
F1
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
Open filing 0001839066-26-000031 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-01Toy Andrew Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)313,4765.32
1,667,692.32

Derived: shares × price per share. Exact value 1667692.32.

9,609,825Direct (D) Yes
F1
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
Open filing 0001838733-26-000015 Read from the filing’s XML Dispute this row
2026-06-17 Filed 2026-06-18Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)2,3604.78
11,280.8

Derived: shares × price per share. Exact value 11280.80.

2,841,211Direct (D) Yes
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.87, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks:
Open filing 0001839066-26-000024 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-06-17OLDAKOWSKI JOSEPH FRANK Officer: VP OF FINANCE AND CONTROLLER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)12,1024.86
58,815.72

Derived: shares × price per share. Exact value 58815.72.

299,067Direct (D) Yes
F1
  • F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25% of restricted stock units (RSUs) originally granted to the Reporting Person on June 16, 2025. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
Open filing 0001801170-26-000161 Read from the filing’s XML Dispute this row
2026-06-15 Filed 2026-06-16Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)6,3504.61
29,273.5

Derived: shares × price per share. Exact value 29273.50.

2,843,571Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001839066-26-000022 Read from the filing’s XML Dispute this row
2026-06-15 Filed 2026-06-16Soares Karen Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,6814.61
21,579.41

Derived: shares × price per share. Exact value 21579.41.

1,567,741Direct (D) Yes
F1, F2
  • F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
  • F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001801170-26-000151 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-11Reynoso Jamie L. Officer: CEO, Medicare Advantage
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)7,2894.91
35,788.99

Derived: shares × price per share. Exact value 35788.99.

2,849,921Direct (D) Yes
F1
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks:
Open filing 0001839066-26-000017 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-05-28Wai Conrad Officer: CEO, Counterpart Health
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)220,4263.99
879,499.74

Derived: shares × price per share. Exact value 879499.74.

1,390,056Indirect (I) By Trust.Yes
F1, F2
  • F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $3.92 to $4.04, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
Open filing 0001971702-26-000010 Read from the filing’s XML Dispute this row
2026-05-18 Filed 2026-05-19Edwards Carladenise Armbrister Director
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)67,1603.42
229,687.2

Derived: shares × price per share. Exact value 229687.20.

285,432Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
Open filing 0001801170-26-000131 Read from the filing’s XML Dispute this row
2026-05-16 Filed 2026-05-18THORNTON JOSEPH CLAY Officer: Interim CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)16,9423.47
58,788.74

Derived: shares × price per share. Exact value 58788.74.

1,217,584Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on May 16, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001801170-26-000130 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-13Priest Brady Patrick Officer: CEO of Clover Care Services
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)98,0393.52
345,097.28

Derived: shares × price per share. Exact value 345097.28.

2,040,222Direct (D) No— Open filing 0001938197-26-000011 Read from the filing’s XML Dispute this row
2026-05-08 Filed 2026-05-12Toy Andrew Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)85,7042.82
241,685.28

Derived: shares × price per share. Exact value 241685.28.

9,923,301Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2026, of 6.25% of the original number of time-based restricted stock units (RSUs) granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001801170-26-000123 Read from the filing’s XML Dispute this row
2026-04-18 Filed 2026-04-21Priest Brady Patrick Officer: CEO of Clover Care Services
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)36,1132.19
79,087.47

Derived: shares × price per share. Exact value 79087.47.

2,138,261Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 18, 2026, of 6.25% of the original number of time-based restricted stock units (RSUs) granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001801170-26-000090 Read from the filing’s XML Dispute this row
2026-04-15 Filed 2026-04-16Reynoso Jamie L. Officer: CEO, Medicare Advantage
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)12,7122.04
25,932.48

Derived: shares × price per share. Exact value 25932.48.

2,857,210Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001839066-26-000015 Read from the filing’s XML Dispute this row
2026-04-15 Filed 2026-04-16Wai Conrad Officer: CEO, Counterpart Health
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)23,4632.04
47,864.52

Derived: shares × price per share. Exact value 47864.52.

1,169,914Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001971702-26-000007 Read from the filing’s XML Dispute this row
2026-04-15 Filed 2026-04-16Toy Andrew Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)60,7652.04
123,960.6

Derived: shares × price per share. Exact value 123960.60.

10,009,005Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001838733-26-000012 Read from the filing’s XML Dispute this row
2026-04-15 Filed 2026-04-16THORNTON JOSEPH CLAY Officer: Interim CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Class A Common Stock
Disposed (D)4,1582.04
8,482.32

Derived: shares × price per share. Exact value 8482.32.

1,234,526Direct (D) No
F1
  • F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
Open filing 0001801170-26-000089 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–6 of 6

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
IMC-Chicago, LLC Option: Put 610,200 SH2,629,962 dollarsHigher by 146,800 Prior quarter: 463,400Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
SIMPLEX TRADING, LLC Option: Call 571,700 SH2,464,027 dollarsLower by 18,600 Prior quarter: 590,300Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
IMC-Chicago, LLC Option: Call 546,600 SH2,355,846 dollarsLower by 91,200 Prior quarter: 637,800Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
GROUP ONE TRADING LLC Option: Call 450,000 SH1,939,500 dollarsLower by 103,700 Prior quarter: 553,700Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
GROUP ONE TRADING LLC Option: Put 292,200 SH1,259,382 dollarsLower by 35,100 Prior quarter: 327,300Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
SIMPLEX TRADING, LLC Option: Put 208,900 SH900,359 dollarsLower by 115,800 Prior quarter: 324,700Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • HRT FINANCIAL LP 151,100 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-000926 Dispute this row
The Vanguard Group Common Stock5.8224,246,03406/30/2025 Filed 2025-07-29SCHEDULE 13GOpen filing 0000932471-25-000785 Dispute this row
BlackRock, Inc. Common Stock7.229,813,64606/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-003014 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,578,969 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020205,260
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,405

Filings made before the SEC required XML are listed, not extracted.

Back to CLOVER HEALTH INVESTMENTS, CORP. /DE